- Home
- CERO vs WNW Comparison
CERO vs WNW Comparison
Compare CERO & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERO
- WNW
- Stock Information
- Founded
- CERO 2017
- WNW 2015
- Country
- CERO United States
- WNW China
- Employees
- CERO N/A
- WNW N/A
- Industry
- CERO
- WNW Catalog/Specialty Distribution
- Sector
- CERO
- WNW Consumer Discretionary
- Exchange
- CERO Nasdaq
- WNW Nasdaq
- Market Cap
- CERO 5.6M
- WNW 5.4M
- IPO Year
- CERO N/A
- WNW 2020
- Fundamental
- Price
- CERO $5.43
- WNW $2.20
- Analyst Decision
- CERO Strong Buy
- WNW
- Analyst Count
- CERO 2
- WNW 0
- Target Price
- CERO $45.00
- WNW N/A
- AVG Volume (30 Days)
- CERO 306.0K
- WNW 104.2K
- Earning Date
- CERO 08-22-2025
- WNW 11-14-2025
- Dividend Yield
- CERO N/A
- WNW N/A
- EPS Growth
- CERO N/A
- WNW N/A
- EPS
- CERO N/A
- WNW 9.06
- Revenue
- CERO N/A
- WNW $158,485.00
- Revenue This Year
- CERO N/A
- WNW N/A
- Revenue Next Year
- CERO N/A
- WNW N/A
- P/E Ratio
- CERO N/A
- WNW $0.27
- Revenue Growth
- CERO N/A
- WNW N/A
- 52 Week Low
- CERO $4.27
- WNW $0.95
- 52 Week High
- CERO $895.40
- WNW $70.00
- Technical
- Relative Strength Index (RSI)
- CERO 32.53
- WNW 56.00
- Support Level
- CERO $4.27
- WNW $1.72
- Resistance Level
- CERO $5.65
- WNW $2.72
- Average True Range (ATR)
- CERO 0.54
- WNW 0.35
- MACD
- CERO -0.17
- WNW 0.06
- Stochastic Oscillator
- CERO 31.12
- WNW 27.84
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.